CVS
CVS Health Corp
Price:  
73.84 
USD
Volume:  
8,048,380.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CVS EV/EBITDA

18.5%
Upside

As of 2024-03-02, the EV/EBITDA ratio of CVS Health Corp (CVS) is 9.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CVS's latest enterprise value is 146,337.95 mil USD. CVS's TTM EBITDA according to its financial statements is 15,174.00 mil USD. Dividing these 2 quantities gives us the above CVS EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.0x - 10.4x 9.9x
Forward P/E multiples 9.5x - 11.5x 10.2x
Fair Price 66.56 - 115.68 87.47
Upside -9.9% - 56.7% 18.5%
73.84 USD
Stock Price
87.47 USD
Fair Price

CVS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 9.64
2024-02-29 9.69
2024-02-28 9.76
2024-02-27 9.85
2024-02-26 9.86
2024-02-23 9.92
2024-02-22 9.91
2024-02-21 9.92
2024-02-20 9.85
2024-02-16 9.91
2024-02-15 9.87
2024-02-14 9.86
2024-02-13 9.87
2024-02-12 9.93
2024-02-09 9.85
2024-02-08 9.75
2024-02-07 9.83
2024-02-06 9.64
2024-02-05 9.53
2024-02-02 9.58
2024-02-01 9.65
2024-01-31 9.69
2024-01-30 9.64
2024-01-29 9.61
2024-01-26 9.57
2024-01-25 9.49
2024-01-24 9.67
2024-01-23 9.75
2024-01-22 9.65
2024-01-19 9.59
2024-01-18 9.65
2024-01-17 9.91
2024-01-16 9.94
2024-01-12 9.87
2024-01-11 10.07
2024-01-10 10.09
2024-01-09 10.18
2024-01-08 10.21
2024-01-05 10.27
2024-01-04 10.20
2024-01-03 10.23
2024-01-02 10.23
2023-12-29 10.07
2023-12-28 10.07
2023-12-27 10.06
2023-12-26 10.07
2023-12-22 10.05
2023-12-21 10.04
2023-12-20 9.93
2023-12-19 9.84